Reed GW, Rossi JE, Cannon CP. Acute myocardial infarction. Lancet (London, England). 2017;389(10065):197–210. https://doi.org/10.1016/S0140-6736(16)30677-8.

Article  PubMed  Google Scholar 

Lavie CJ, Carbone S, Slipczuk L. Physical activity with or without dietary intervention for the prevention of cardiovascular diseases. J Sport Health Sci. 2024;13(6):753–5. https://doi.org/10.1016/j.jshs.2024.05.012.

Article  PubMed  PubMed Central  Google Scholar 

Fu WB, Wang WE, Zeng CY. Wnt signaling pathways in myocardial infarction and the therapeutic effects of Wnt pathway inhibitors. Acta Pharmacol Sin. 2019;40(1):9–12. https://doi.org/10.1038/s41401-018-0060-4.

Article  CAS  PubMed  Google Scholar 

Daskalopoulos EP, Hermans KCM, Janssen BJA, Matthijs BW. Targeting the Wnt/frizzled signaling pathway after myocardial infarction: a new tool in the therapeutic toolbox? Trends Cardiovasc Med. 2013;23(4):121–7. https://doi.org/10.1016/j.tcm.2012.09.010.

Article  CAS  PubMed  Google Scholar 

Leach JP, Heallen T, Zhang M, Rahmani M, Morikawa Y, Hill MC, et al. Hippo pathway deficiency reverses systolic heart failure after infarction. Nature. 2017;550(7675):260–4. https://doi.org/10.1038/nature24045.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qin YY, Huang XR, Zhang J, Wu W, Chen J, Wan S, et al. Neuropeptide Y attenuates cardiac remodeling and deterioration of function following myocardial infarction. Molecular Ther J American Soc. Gene Ther. 2024;32(2):559–61. https://doi.org/10.1016/j.ymthe.2023.12.013.

Article  CAS  Google Scholar 

Rao SV, O’Donoghue ML, Ruel M, Rab,T, Tamis-Holland JE, Alexander JH, … Williams MS. 2025 ACC/AHA/ACEP/NAEMSP/SCAI guideline for the management of patients with acute coronary syndromes: A report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2025;151(13): e771–e862. https://doi.org/10.1161/CIR.0000000000001309

Grinstein J, Cannon CP. Aspirin resistance: current status and role of tailored therapy. Clin Cardiol. 2012;35(11):673–81. https://doi.org/10.1002/clc.22031.

Article  PubMed  PubMed Central  Google Scholar 

Elsayed OR, Wakeel LME, Saleh MA, Ahmed MA. The impact of alpha lipoic acid administration on oxidative stress markers and occurrence of no-reflow phenomenon in post myocardial infarction patients. Future J Pharm Sci. 2025;11(1):1–13. https://doi.org/10.1186/s43094-025-00805-7

Chen X, Li X, Sun J, Lin Y, Li Y, Lv X, … Jia X. Mongolian medicine Eerdun-Wurile promotes myocardial regeneration by regulating MVDA in zebrafish. Cell Regeneration . 2025;14(1): 22. https://doi.org/10.1186/s13619-025-00235-z

Chen KJ, Zhang Y, Zhu XY, Yu S, Xie Y, Jin CJ, et al. GSTM1 suppresses cardiac fibrosis post-myocardial infarction through inhibiting lipid peroxidation and ferroptosis. Military Med Res. 2025;12(1):26. https://doi.org/10.1186/s40779-025-00610-6.

Article  CAS  Google Scholar 

Wang D, Li L, Zhang F, Liu Q, Wang WL, Wang ZX, et al. SLC1A5 mediates myocardial damage after myocardial infarction by triggering cardiomyocyte ferroptosis. Biochem Pharmacol. 2025;239:117047. https://doi.org/10.1016/j.bcp.2025.117047.

Article  CAS  PubMed  Google Scholar 

Zhang K, Yang X, Wang Y, Yu Y, Huang N, Li G, et al. Artificial intelligence in drug development. Nature Medicine. 2025;31(1):45–59. https://doi.org/10.1038/s41591-024-03434-4.

Article  CAS  PubMed  Google Scholar 

Lalu MM, Mazzarello S, Zlepnig J, Dong YYR, Montroy J, McIntyre L, et al. Safety and efficacy of adult stem cell therapy for acute myocardial infarction and ischemic heart failure (SafeCell Heart): A systematic review and meta-analysis. Stem Cells Translational Med. 2018;7(12):857–66. https://doi.org/10.1002/sctm.18-0120.

Article  Google Scholar 

Richards DJ, Tan Y, Coyle R, Li Y, Xu R, Yeung N, et al. Nanowires and electrical stimulation synergistically improve functions of hiPSC cardiac spheroids. Nano Lett. 2016;16(7):4670–8. https://doi.org/10.1021/acs.nanolett.6b02093.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mottaghitalab F, Farokhi M, Fatahi Y, Atyabi F, Dinarvand R. New insights into designing hybrid nanoparticles for lung cancer: Diagnosis and treatment. J Control Release. 2019;295:250–67. https://doi.org/10.1016/j.jconrel.2019.01.009.

Article  CAS  PubMed  Google Scholar 

Ernsting MJ, Murakami M, Roy A, Li SD. Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles. J Control Release. 2013;172(3):782–94. https://doi.org/10.1016/j.jconrel.2013.09.013.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hasabnis GK, Altintas Z. Cardiac Troponin I-responsive nanocomposite materials for voltammetric monitoring of acute myocardial infarction. ACS Omega. 2024;9(28):30737–50. https://doi.org/10.1021/acsomega.4c03252.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang J, Shen S, Lin R, Huang J, Pu C, Chen P, … Hou H. Highly stretchable and biocompatible wrinkled nanoclay-composite hydrogel with enhanced sensing capability for precise detection of myocardial infarction. Adv Mater . 2023;35(9): e2209497. https://doi.org/10.1002/adma.202209497.

Chapter  Google Scholar 

Muñoz M, Eren Cimenci C, Goel K, Comtois-Bona M, Hossain M, McTiernan C, et al. Nanoengineered sprayable therapy for treating myocardial infarction. ACS Nano. 2022;16(3):3522–37. https://doi.org/10.1021/acsnano.1c08890.

Article  CAS  PubMed  Google Scholar 

Tsutsui H. Mitochondrial oxidative stress and heart failure. Internal Medicine (Tokyo, Japan). 2006;45(13):809–13. https://doi.org/10.2169/internalmedicine.45.1765.

Article  PubMed  Google Scholar 

Yao T, Ying X, Zhao Y, Yuan A, He Q, Tong H, et al. Vitamin D receptor activation protects against myocardial reperfusion injury through inhibition of apoptosis and modulation of autophagy. Antioxid Redox Signal. 2015;22(8):633–50. https://doi.org/10.1089/ars.2014.5887.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xiang L, Zhang Q, Chi C, Wu G, Lin Z, Li J, et al. Curcumin analog A13 alleviates oxidative stress by activating Nrf2/ARE pathway and ameliorates fibrosis in the myocardium of high-fat-diet and streptozotocin-induced diabetic rats. Diabetol Metab Syndr. 2020;12:1. https://doi.org/10.1186/s13098-019-0485-z.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fan K, Huang W, Qi H, Song C, He C, Liu Y, et al. The Egr-1/miR-15a-5p/GPX4 axis regulates ferroptosis in acute myocardial infarction. European. J Pharmacol. 2021;909:174403. https://doi.org/10.1016/j.ejphar.2021.174403.

Article  CAS  Google Scholar 

Liu X, Chen B, Chen, J, Wang X, Dai X, Li Y, … Yang Y. A Cardiac-targeted nanozyme interrupts the inflammation-free radical cycle in myocardial infarction. Adv Mater . 2024;36(2): e2308477. https://doi.org/10.1002/adma.202308477.

Hu D, Li R, Li Y, Wang M, Wang L, Wang S, … Wei, Q. Inflammation-targeted nanomedicines alleviate oxidative stress and reprogram macrophages polarization for myocardial infarction treatment. Adv Sci . 2024;11(21): e2308910. https://doi.org/10.1002/advs.202308910.

Liu W, Zhao N, Yin Q, Zhao X, Guo K, Xian Y, et al. Injectable hydrogels encapsulating dual-functional Au@Pt core-shell nanoparticles regulate infarcted microenvironments and enhance the therapeutic efficacy of stem cells through antioxidant and electrical integration. ACS Nano. 2023;17(3):2053–66. https://doi.org/10.1021/acsnano.2c07436.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang J, Wang S, Sun Q, Zhang J, Shi X, Yao M, et al. Peroxynitrite-free nitric oxide-embedded nanoparticles maintain nitric oxide homeostasis for effective revascularization of myocardial infarcts. ACS Nano. 2024;18(47):32650–71. https://doi.org/10.1021/acsnano.4c10118.

Article  CAS  PubMed  Google Scholar 

Sun M, Hu N, Gao Y, Lv N, Fu X, Li Y, et al. Platelet membrane-encapsulated nanocomplexes based on profundity scavenging ROS strategy for myocardial infarction Therapy. Adv Healthcare Mater. 2024;13(8):e2303101. https://doi.org/10.1002/adhm.202303101.

Article  CAS  Google Scholar 

Gong Y, Xiao Y, Zhao C, Deng H, Liu H, Ke S, et al. Ultrasmall PtIr bimetallic nanozyme treats myocardial infarction via ischemic/inflammatory cardiac microenvironment remodeling. ACS Nano. 2025;19(14):13723–39. https://doi.org/10.1021/acsnano.4c14869.

Article  CAS  PubMed  Google Scholar 

Prabhu SD, Frangogiannis NG. The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis. Circ Res. 2016;119(1):91–112. https://doi.org/10.1161/CIRCRESAHA.116.303577.

Article  CAS  PubMed  PubMed Central